Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


Phillip B. Berkey Moheno

Phillip B. Berkey Moheno

SanRx Pharmaceutical Inc, USA

Title: Calcium folate for flu prevention and control


Phillip B. Berkey Moheno holds a BS and a Candidate in Philosophy in Biochemistry from the University of California, Los Angeles, and a PhD in Confluent Education from the University of California, Santa Barbara. In addition he has more than 20 years of research experience into the anti-cancer properties of pterins. He has published 12 papers in reputed journals.


Calcium Folate is the excess calcium salt of the vitamin folic acid. Folic acid is sensitive to acidic-oxidative conditions and, in the presence of excess Ca+2 as well, is transformed into pterins and calcium pterins. This pilot observational study describes the use of CaFolate-derived calcium pterin 6-carboxylate in the treatment of certain immune-related ailments. Patients with various immune-associated disorders were directed to take ad libitum 25-76 mg of CaFolate (300-900 µg folic acid equivalent) orally per day, as an adjuvant therapy, and to collect personal and medical assessments. The users reported no flu/colds (>20/20 reporting none during the cold and flu season), greater energy/stamina (8/8 reporting increased), less osteoarthritis pain (10/11 reporting improvement), diminished mouth sores due to chemotherapy (2/2 reporting significant clearance), and cancer remissions (4/5 reported plus 1 transient improvement in a terminal case). These observational findings identify certain clinical endpoints for future matched group, randomized, double-blind, placebo-controlled clinical trials. One such clinical trial is underway in osteoarthritis.

Speaker Presentations

Speaker PDFs

Speaker PPTs Click Here